RayzeBio inc (DELISTED) (RYZB:DL)
62.49
0.00 (0.00%)
USD |
NASDAQ |
Mar 06, 16:00
RayzeBio Enterprise Value: 3.204B for March 6, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| March 06, 2024 | 3.204B |
| March 05, 2024 | 3.204B |
| March 04, 2024 | 3.204B |
| March 01, 2024 | 3.204B |
| February 29, 2024 | 3.204B |
| February 28, 2024 | 3.204B |
| February 27, 2024 | 3.204B |
| February 26, 2024 | 3.204B |
| February 23, 2024 | 3.204B |
| February 22, 2024 | 3.204B |
| February 21, 2024 | 3.204B |
| February 20, 2024 | 3.204B |
| February 16, 2024 | 3.201B |
| February 15, 2024 | 3.199B |
| February 14, 2024 | 3.200B |
| February 13, 2024 | 3.198B |
| February 12, 2024 | 3.198B |
| February 09, 2024 | 3.194B |
| February 08, 2024 | 3.191B |
| February 07, 2024 | 3.184B |
| February 06, 2024 | 3.182B |
| February 05, 2024 | 3.183B |
| February 02, 2024 | 3.182B |
| February 01, 2024 | 3.183B |
| January 31, 2024 | 3.181B |
| Date | Value |
|---|---|
| January 30, 2024 | 3.180B |
| January 29, 2024 | 3.181B |
| January 26, 2024 | 3.180B |
| January 25, 2024 | 3.180B |
| January 24, 2024 | 3.171B |
| January 23, 2024 | 3.172B |
| January 22, 2024 | 3.166B |
| January 19, 2024 | 3.169B |
| January 18, 2024 | 3.169B |
| January 17, 2024 | 3.163B |
| January 16, 2024 | 3.172B |
| January 12, 2024 | 3.172B |
| January 11, 2024 | 3.163B |
| January 10, 2024 | 3.175B |
| January 09, 2024 | 3.172B |
| January 08, 2024 | 3.169B |
| January 05, 2024 | 3.174B |
| January 04, 2024 | 3.165B |
| January 03, 2024 | 3.163B |
| January 02, 2024 | 3.172B |
| December 29, 2023 | 3.185B |
| December 28, 2023 | 3.155B |
| December 27, 2023 | 3.159B |
| December 26, 2023 | 3.139B |
| December 22, 2023 | 1.292B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
561.83M
Minimum
Oct 27 2023
3.204B
Maximum
Feb 20 2024
1.800B
Average
1.054B
Median
Dec 14 2023
Enterprise Value Benchmarks
| Bristol-Myers Squibb Co | 160.18B |
| Karuna Therapeutics Inc (DELISTED) | 11.34B |
| Ambrx Biopharma Inc (DELISTED) | 1.542B |
| Pfizer Inc | 208.36B |
| Mirati Therapeutics Inc (DELISTED) | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -18.19M |
| Total Expenses (Quarterly) | 21.65M |
| EPS Diluted (Quarterly) | -1.26 |